America February 5, 2024
Novo Holdings Buying Catalent In $16.5B Deal
In a seismic move within the pharmaceutical industry, Novo Holdings, the controlling shareholder in Novo Nordisk Foundation, has unveiled plans…
America February 5, 2024
In a seismic move within the pharmaceutical industry, Novo Holdings, the controlling shareholder in Novo Nordisk Foundation, has unveiled plans…
By Rihem Akkouche